Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.

scientific article published on 26 August 2013

Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/ONC.2013.351
P698PubMed publication ID23975423

P50authorPaul HofmanQ30507739
Jessica Zucman-RossiQ43376269
Pascal AndujarQ57334400
Françoise Le Pimpec-BarthesQ57754127
Jean Charles NaultQ58392544
Didier JeanQ60380278
Marie-Claude JaurandQ61312611
P2093author name stringM-C Copin
A Tallet
A Renier
A Cazes
F Galateau-Sallé
I Hysi
P2860cites workHallmarks of Cancer: The Next GenerationQ22252312
Germline BAP1 mutations predispose to malignant mesotheliomaQ24635326
Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesotheliomaQ28387443
Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseasesQ28389566
Highly recurrent TERT promoter mutations in human melanomaQ29614798
TERT promoter mutations in familial and sporadic melanomaQ29614920
Mesothelioma not associated with asbestos exposureQ33390481
Alternative lengthening of telomeres: models, mechanisms and implicationsQ34107386
p16(INK4a) -mediated suppression of telomerase in normal and malignant human breast cellsQ34137912
Regulation of the human catalytic subunit of telomerase (hTERT).Q34180715
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesotheliomaQ34190027
Mesothelial cells: their structure, function and role in serosal repairQ34769996
Telomerase activity in pleural malignant mesotheliomas.Q35103570
Linking abnormal mitosis to the acquisition of DNA damageQ36455900
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewalQ36762656
Increased copy number of the TERT and TERC telomerase subunit genes in cancer cellsQ37164678
Human telomerase expression regulationQ37905799
Oncogene- and tumor suppressor gene-mediated suppression of cellular senescenceQ37950784
Molecular changes in mesothelioma with an impact on prognosis and treatmentQ37988955
Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas.Q38291755
Telomerase activity in human pleural mesotheliomaQ40818515
Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesotheliomaQ43579146
Interleukin-8 prevents oxidative stress-induced human endothelial cell senescence via telomerase activationQ46138488
p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestosQ47988404
In vitro effects of recombinant human interferon gamma on human mesothelioma cell lines.Q54230847
Multiple Mechanisms of Telomere Maintenance Exist and Differentially Affect Clinical Outcome in Diffuse Malignant Peritoneal MesotheliomaQ60589812
Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesotheliomaQ81556073
P433issue28
P407language of work or nameEnglishQ1860
P921main subjectoverexpressionQ61643320
P304page(s)3748-3752
P577publication date2013-08-26
P1433published inOncogeneQ1568657
P1476titleOverexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma
P478volume33

Reverse relations

cites work (P2860)
Q26738705Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications
Q30459452Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer
Q35901458Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis
Q37626548Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma
Q40857012Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness
Q38972707Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles
Q89829094Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival
Q48857394High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression
Q59350396Investigating the Promoter of FAT10 Gene in HCC Patients
Q41335241KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway
Q49232092Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma.
Q64933510Mesotheliomas in Genetically Engineered Mice Unravel Mechanism of Mesothelial Carcinogenesis.
Q52956152Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.
Q58550783Not the same thing: metastatic PTCs have a different background than ATCs
Q35001781Oncogenic mutation profiling in new lung cancer and mesothelioma cell lines
Q35068013TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR
Q33688439TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas
Q38232447Telomerase promoter mutations in cancer: an emerging molecular biomarker?
Q53232555Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
Q91028354Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population
Q54374929Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.
Q55443450Telomere Maintenance Mechanisms in Cancer.
Q91744753The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models
Q33709979The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors
Q39076273The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas
Q93117015The role of telomeres and telomerase in cirrhosis and liver cancer
Q26739925Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
Q33687535Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry?
Q38760235Understanding TERT Promoter Mutations: A Common Path to Immortality.

Search more.